Three tactics to stem the tide of criminal prosecutions
Less than 10% of East European prevention spending is for vulnerable groups
New studies strengthen evidence that drug addiction is a disease of the brain; substitution therapy necessary
Evidence-based treatment of drug users needed to strengthen human rights, stem drug use, and halt the HIV epidemic
'The business of public health': new research on financing of HIV programmes
Mass testing campaign unjustified if people fail to receive treatment, activist argues
Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes
Neurocognitive impairment linked to prior low CD4 cell count, even if on current suppressive HIV treatment
Prevention strategies need to target both early and chronic HIV infection
CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level
Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result
UK: one in six gay men testing HIV-positive were infected recently
Penal reform, decriminalisation of illicit drugs, and increased advocacy all central to improving prisoners' health
Starting ART two weeks after TB treatment reduces death risk by one-third in people with HIV
Once-daily extended-release nevirapine works as well as twice-daily formulation
Experimental integrase inhibitor GSK-572 shows continued promise
Early treatment for infants cheaper than delaying treatment, CHER study shows
Ugandan study shows why human rights are central to HIV prevention with African men who have sex with men
